
    
      This study is to evaluate pharmacokinetics and safety between DWC20151 and DWC20152 in
      healthy male subjects.

      Study design is randomized, open-labeled, oral dose, crossover design. This study will
      conducted with 2 separated part (Part A, Part B).
    
  